Aclaris Therapeutics (ACRS) Return on Capital Employed Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Aclaris Therapeutics | 586.09 Mn | 586.09 Mn | 1.60 Mn | -782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -782.00 |
| Dec 31, 2025 | -1,724.00 |
| Sep 30, 2025 | -6,477.00 |
| Jun 30, 2025 | -5,272.00 |
| Mar 31, 2025 | -3,911.00 |
| Dec 31, 2024 | -4,533.00 |
| Sep 30, 2024 | 89.00 |
| Jun 30, 2024 | -1,075.00 |
| Mar 31, 2024 | 1,080.00 |
| Dec 31, 2023 | 3,513.00 |
| Sep 30, 2023 | 2,232.00 |
| Jun 30, 2023 | 3,877.00 |
| Mar 31, 2023 | 8,428.00 |
| Dec 31, 2022 | 6,631.00 |
| Sep 30, 2022 | 4,539.00 |
| Jun 30, 2022 | 2,509.00 |
| Mar 31, 2022 | 971.00 |
| Dec 31, 2021 | 1,628.00 |
| Sep 30, 2021 | 2,380.00 |
| Jun 30, 2021 | 1,296.00 |
| Mar 31, 2021 | -2,977.00 |
| Dec 31, 2020 | -6,748.00 |
| Sep 30, 2020 | -5,559.00 |
| Jun 30, 2020 | -6,094.00 |
| Mar 31, 2020 | -10,011.00 |
| Dec 31, 2019 | -6,498.00 |
| Sep 30, 2019 | -3,020.00 |
| Jun 30, 2019 | -1,205.00 |
| Mar 31, 2019 | -991.00 |
| Dec 31, 2018 | -2,349.00 |